Study to Evaluate TNX-601 ER Monotherapy Versus Placebo in Patients With Major Depressive Disorder (MDD)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Gregory Sullivan, MD
Tonix Pharmaceuticals
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
27 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Preferred Research Partners
Little Rock, Arkansas, United States
- Cenexel Cit - Bellflower
Bellflower, California, United States
- Behavioral Research Specialists
Glendale, California, United States
- Synergy Research
Lemon Grove, California, United States
- Excell Research
Oceanside, California, United States
- Ncr Research Institute
Orange, California, United States
- Cenexel Cit - Riverside
Riverside, California, United States
- Artemis Institute for Clinical Research
San Diego, California, United States
- Cenexel Cnr - Sherman Oaks
Sherman Oaks, California, United States
- Viking Clinical Research
Temecula, California, United States
- Mountain View Clinical Research
Denver, Colorado, United States
- Ct Clinical Research Associates
Cromwell, Connecticut, United States
- Gulfcoast Clinical Research Center
Fort Myers, Florida, United States
- Clinical Neuroscience Solutions - Jacksonville
Jacksonville, Florida, United States
- West Broward Outpatient Clinic
Lauderhill, Florida, United States
- Segal Trials - North Miami
Miami Lakes, Florida, United States
- Clinical Neuroscience Solutions - Orlando
Orlando, Florida, United States
- Cenexel Acmr - Atlanta
Atlanta, Georgia, United States
- Cenexel Research - Decatur
Decatur, Georgia, United States
- Northwest Clinical Trials
Boise, Idaho, United States
- Chicago Research Center
Chicago, Illinois, United States
- Cenexel Hri - Berlin
Berlin, New Jersey, United States
- Summit Research Network
Portland, Oregon, United States
- Clinical Neuroscience Solutions - Memphis
Memphis, Tennessee, United States
- Donald J. Garcia, Jr.
Austin, Texas, United States
- Futuresearch Trials of Dallas
Dallas, Texas, United States
- Core Clinical Research
Everett, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 2 Mar 2023
- Primary completion
- 29 Sept 2023
- Completion
- 29 Sept 2023
- Last update posted
- 17 Feb 2025
- Registered enrollment
- 132
- Registry id
- NCT05686408
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.